Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and cpg

HIGHLIGHTS

• who: Luis Ontiveros-Padilla and colleagues from the University Medical Center Groningen, Statens Serum Institut (SSI), Denmark have published the paper: Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG, in the Journal: (JOURNAL)
• how: Statistics All in_vitro and in_vivo data were analyzed using a parametric test except survival data. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
• future: Even if further studies in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.